Income Statement
PTC THERAPEUTICS, INC.
PTCT
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
1,730.66 | 806.78 | 937.82 | 698.80 | 538.59 | 380.77 | - | - | 194.39 | 82.71 | 36.77 | 25.25 | 34.70 |
|
Cost of Revenue
|
- | - | - | - | - | - | 12.14 | - | - | - | - | - | - |
|
Gross Profit
|
1,730.66 | 806.78 | 937.82 | 698.80 | 538.59 | 380.77 | -12.14 | - | 194.39 | 82.71 | 36.77 | 25.25 | 34.70 |
|
Operating Expenses
|
863.72 | 1,109.35 | 1,377.32 | 1,146.21 | 913.04 | 812.53 | 548.14 | 380.42 | 258.68 | 214.76 | 203.90 | 124.66 | 80.09 |
|
Research & Development
|
455.25 | 534.48 | 666.56 | 651.50 | 540.68 | 477.64 | 257.45 | 171.98 | 117.46 | 117.63 | 121.82 | 79.84 | 54.88 |
|
Selling, General & Administrative
|
347.14 | 300.91 | 332.54 | 326.00 | 285.77 | 245.16 | 202.54 | 153.55 | 121.27 | 97.13 | 82.08 | 44.82 | 25.22 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
866.94 | -302.57 | -439.50 | -447.41 | -374.44 | -431.77 | -560.27 | -380.42 | -64.29 | -132.06 | -167.13 | -99.41 | -45.40 |
|
Non-Operating Income
|
170.32 | 60.55 | 256.61 | 140.08 | 143.90 | -28.84 | -320.35 | -247.22 | 13.37 | 9.48 | 2.83 | -0.97 | 6.18 |
|
Interest Income
|
74.08 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
5.53 | 5.52 | 30.90 | 6.36 | 5.44 | 18.11 | 13.29 | 12.39 | 11.59 | 10.86 | 3.96 | - | - |
|
Other Non-Op Income / Expense
|
-18.09 | 6.54 | 10.13 | -49.21 | -57.88 | 85.19 | 13.72 | 0.13 | -1.28 | -1.21 | -0.47 | -0.21 | 0.04 |
|
Income Before Tax
|
696.62 | -363.12 | -696.11 | -587.49 | -518.34 | -402.93 | -239.93 | -5.09 | -77.67 | -61.45 | 119.00 | -98.45 | -51.57 |
|
Income Tax Expense
|
13.98 | 0.18 | -69.51 | -28.47 | 5.56 | 35.23 | 11.65 | -5.12 | 1.34 | 0.57 | 0.49 | -4.69 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
682.64 | -363.30 | -626.60 | -559.02 | -523.90 | -438.16 | -251.58 | -128.08 | -79.00 | -142.11 | -170.45 | -93.75 | -51.57 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
905.75 | -226.91 | -202.91 | -318.57 | -310.31 | -388.28 | -528.09 | -354.33 | -46.61 | -132.06 | -167.13 | -99.41 | -45.40 |
|
Earnings Per Share (Basic)
|
8.58 | -4.73 | -8.37 | -7.79 | -7.43 | - | -4.27 | - | - | - | - | -2.97 | -5.18 |
|
Diluted EPS
|
7.78 | -4.73 | -8.37 | -7.79 | -7.43 | - | - | - | - | - | - | -2.97 | -5.18 |
|
Weighted Average Shares
|
79.53 | 76.85 | 74.84 | 71.73 | 70.47 | - | - | - | - | - | - | 31.57 | 12.83 |
|
Diluted Weighted Avg Shares
|
88.31 | 76.85 | 74.84 | 71.73 | 70.47 | - | - | - | - | - | - | 31.57 | 12.83 |
|
Comprehensive Income
|
719.03 | -387.90 | -632.69 | -529.94 | -487.23 | -488.53 | -263.62 | -5.09 | -73.55 | -142.40 | -170.91 | -94.56 | -51.50 |